Akebia Therapeutics Statistics
NASDAQ: AKBAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.8734-0.0051 (-0.58%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Akebia Therapeutics by the numbers
Akebia Therapeutics has a market capitalization of $242.0 million based on 277.11M shares outstanding. With trailing EPS of $-0.12, Akebia Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.0% below its 50-day average and 28.6% below its 200-day average.
Average daily trading volume is 6.09M shares, or about $5.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AKBA valuation vs. peer median
| Metric | AKBA | Peer median | Difference |
|---|---|---|---|
| Market cap | $242.02M | $242.44M | -0% |
| Avg. volume | 6.09M | 486.82K | +1151% |
Peer median across 8 companies: VCRE, LFCR, CAMP, PYXS, VOGX, QTTB, IMRX, ZNTL.
Valuation
- Market cap
- $242.02M
- EPS (TTM)
- $-0.12
- Shares outstanding
- 277.11M
Price and trading
- Previous close
- 0.8785
- Open
- 0.8633
- Day range
- 0.8633 – 0.8871
- 52-week range
- 0.814 – 3.20
- 52-week change
- -70.39%
- 50-day moving average
- 0.9702
- Beta
- —
- Volume
- 9.16M
- Average volume
- 6.09M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 5, 2026
Additional statistics
- Market Cap
- 242.02M
- Forward Pe
- -2.43
- Eps
- -0.12
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.20
- Week52 Low
- 0.81
- Avg Volume
- 6.09M
- Shares Outstanding
- 277.11M
- Ma50
- 0.97
- Ma200
- 1.22
- Earnings Date
- Aug 5, 2026
- Pct From52w High
- -72.71%
- Pct From52w Low
- 7.30%